-
1
-
-
0035806484
-
National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000
-
P Eifel JA Axelson J Costa J Crowley WJ Curran Jr A Deshler S Fulton CB Hendricks M Kemeny AB Kornblith TA Louis M Markman R Mayer D Roter 2001 National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000 J Natl Cancer Inst 93 979 989
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 979-989
-
-
Eifel, P.1
Axelson, J.A.2
Costa, J.3
Crowley, J.4
Curran Jr., W.J.5
Deshler, A.6
Fulton, S.7
Hendricks, C.B.8
Kemeny, M.9
Kornblith, A.B.10
Louis, T.A.11
Markman, M.12
Mayer, R.13
Roter, D.14
-
4
-
-
0035879298
-
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer
-
CL Shapiro J Manola M Leboff 2001 Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer J Clin Oncol 19 3306 3311
-
(2001)
J Clin Oncol
, vol.19
, pp. 3306-3311
-
-
Shapiro, C.L.1
Manola, J.2
Leboff, M.3
-
6
-
-
0032537396
-
Tamoxifen for early breast cancer: An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group 1998 Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 351 1451 1467
-
(1998)
Lancet
, vol.351
, pp. 1451-1467
-
-
-
7
-
-
0031045147
-
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens
-
T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa 1997 Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens Br J Cancer 75 602 605
-
(1997)
Br J Cancer
, vol.75
, pp. 602-605
-
-
Saarto, T.1
Blomqvist, C.2
Valimaki, M.3
Makela, P.4
Sarna, S.5
Elomaa, I.6
-
8
-
-
0030070093
-
Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
-
TJ Powles T Hickish JA Kanis A Tidy S Ashley 1996 Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women J Clin Oncol 14 78 84
-
(1996)
J Clin Oncol
, vol.14
, pp. 78-84
-
-
Powles, T.J.1
Hickish, T.2
Kanis, J.A.3
Tidy, A.4
Ashley, S.5
-
9
-
-
0026585852
-
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
-
RR Love RB Mazess HS Barden S Epstein PA Newcomb VC Jordan PP Carbone DL DeMets 1992 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer N Eng J Med 326 852 856
-
(1992)
N Eng J Med
, vol.326
, pp. 852-856
-
-
Love, R.R.1
Mazess, R.B.2
Barden, H.S.3
Epstein, S.4
Newcomb, P.A.5
Jordan, V.C.6
Carbone, P.P.7
Demets, D.L.8
-
10
-
-
0028033883
-
Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years
-
RR Love HS Barden RB Mazess S Epstein RJ Chappell 1994 Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years Arch Intern Med 154 2585 2588
-
(1994)
Arch Intern Med
, vol.154
, pp. 2585-2588
-
-
Love, R.R.1
Barden, H.S.2
Mazess, R.B.3
Epstein, S.4
Chappell, R.J.5
-
13
-
-
0032412151
-
Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer
-
A Resch E Biber M Seifert H Resch 1998 Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer Acta Oncol 37 661 664
-
(1998)
Acta Oncol
, vol.37
, pp. 661-664
-
-
Resch, A.1
Biber, E.2
Seifert, M.3
Resch, H.4
-
14
-
-
0032537990
-
Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
-
B Fisher JP Constantino DL Wickerham CK Redmon M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins M Daly S Wieand E Tan-Chiu L Ford N Wolmark 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371 1388
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1371-1388
-
-
Fisher, B.1
Constantino, J.P.2
Wickerham, D.L.3
Redmon, C.K.4
Kavanah, M.5
Cronin, W.M.6
Vogel, V.7
Robidoux, A.8
Dimitrov, N.9
Atkins, J.10
Daly, M.11
Wieand, S.12
Tan-Chiu, E.13
Ford, L.14
Wolmark, N.15
-
16
-
-
7444259675
-
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
-
PE Goss JN Ingle S Martino NJ Robert HB Muss MJ Piccart M Castiglioni D Tu LE Shepherd KI Pritchard RB Livingston NE Davidson L Norton EA Perez JS Abrams P Therasse MJ Palmer JL Pater 2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Eng J Med 349 1793 1802
-
(2003)
N Eng J Med
, vol.349
, pp. 1793-1802
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
Robert, N.J.4
Muss, H.B.5
Piccart, M.J.6
Castiglioni, M.7
Tu, D.8
Shepherd, L.E.9
Pritchard, K.I.10
Livingston, R.B.11
Davidson, N.E.12
Norton, L.13
Perez, E.A.14
Abrams, J.S.15
Therasse, P.16
Palmer, M.J.17
Pater, J.L.18
-
17
-
-
10744223655
-
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
-
RC Coombes E Hall LJ Gibson R Paridaens J Jassem T Delozier SE Jones I Alvarez G Bertelli O Ortmann AS Coates E Bajetta D Dodwell RE Coleman LJ Fallowfield E Mickiewicz J Andersen PE Lønning G Cocconi A Stewart N Stuart CF Snowdon M Carpentieri G Massimini J Bliss 2004 A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 350 1081 1092
-
(2004)
N Engl J Med
, vol.350
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
Paridaens, R.4
Jassem, J.5
Delozier, T.6
Jones, S.E.7
Alvarez, I.8
Bertelli, G.9
Ortmann, O.10
Coates, A.S.11
Bajetta, E.12
Dodwell, D.13
Coleman, R.E.14
Fallowfield, L.J.15
Mickiewicz, E.16
Andersen, J.17
Lønning, P.E.18
Cocconi, G.19
Stewart, A.20
Stuart, N.21
Snowdon, C.F.22
Carpentieri, M.23
Massimini, G.24
Bliss, J.25
more..
-
18
-
-
0031003458
-
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: A randomized study in premenopausal breast cancer patients
-
T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa 1997 Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients J Clin Oncol 15 1341 1347
-
(1997)
J Clin Oncol
, vol.15
, pp. 1341-1347
-
-
Saarto, T.1
Blomqvist, C.2
Valimaki, M.3
Makela, P.4
Sarna, S.5
Elomaa, I.6
-
19
-
-
0031057249
-
Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study
-
PD Delmas R Balena E Confravreux C Hardouin P Hardy A Bremond 1997 Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study J Clin Oncol 13 955 962
-
(1997)
J Clin Oncol
, vol.13
, pp. 955-962
-
-
Delmas, P.D.1
Balena, R.2
Confravreux, E.3
Hardouin, C.4
Hardy, P.5
Bremond, A.6
-
20
-
-
0032490125
-
Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer
-
TJ Powles E McCloskey AH Paterson S Ashley VA Tidy A Nevantaus K Rosenqvist J Kanis 1998 Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer J Natl Cancer Inst 90 704 708
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 704-708
-
-
Powles, T.J.1
McCloskey, E.2
Paterson, A.H.3
Ashley, S.4
Tidy, V.A.5
Nevantaus, A.6
Rosenqvist, K.7
Kanis, J.8
-
21
-
-
0035196356
-
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. the effect of adjuvant clodronate treatment
-
L Vehmanen T Saarto I Elomaa P Makela M Valimaki C Blomqvist 2001 Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment Eur J Cancer 37 2373 2378
-
(2001)
Eur J Cancer
, vol.37
, pp. 2373-2378
-
-
Vehmanen, L.1
Saarto, T.2
Elomaa, I.3
Makela, P.4
Valimaki, M.5
Blomqvist, C.6
-
22
-
-
4544349095
-
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure
-
L Vehmanen T Saarto J Risteli L Risteli C Blomqvist I Elomaa 2004 Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure Breast Cancer Res Treat 87 181 188
-
(2004)
Breast Cancer Res Treat
, vol.87
, pp. 181-188
-
-
Vehmanen, L.1
Saarto, T.2
Risteli, J.3
Risteli, L.4
Blomqvist, C.5
Elomaa, I.6
-
24
-
-
0034037097
-
Osteoporosis due to cancer treatment: Pathogenesis and management
-
J Pfeilschifter IJ Diel 2000 Osteoporosis due to cancer treatment: pathogenesis and management J Clin Oncol 18 1570 1593
-
(2000)
J Clin Oncol
, vol.18
, pp. 1570-1593
-
-
Pfeilschifter, J.1
Diel, I.J.2
-
25
-
-
12144289279
-
Ten years experience with alendronate for osteoporosis in postmenopausal women
-
HG Bone D Hosking JP Devogelaer JR Tucci RD Emkey RP Tonino JA Rodriguez-Portales RW Downs J Gupta AC Santora UA Liberman 2004 Ten years experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 350 1189 1199
-
(2004)
N Engl J Med
, vol.350
, pp. 1189-1199
-
-
Bone, H.G.1
Hosking, D.2
Devogelaer, J.P.3
Tucci, J.R.4
Emkey, R.D.5
Tonino, R.P.6
Rodriguez-Portales, J.A.7
Downs, R.W.8
Gupta, J.9
Santora, A.C.10
Liberman, U.A.11
-
26
-
-
7144223389
-
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group
-
GN Hortobagyi RL Theriault A Lipton L Porter D Blayney C Sinoff H Wheeler JF Simeone JJ Seaman RD Knight M Heffernan K Mellars DJ Reitsma 1998 Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group J Clin Oncol 16 2038 2044
-
(1998)
J Clin Oncol
, vol.16
, pp. 2038-2044
-
-
Hortobagyi, G.N.1
Theriault, R.L.2
Lipton, A.3
Porter, L.4
Blayney, D.5
Sinoff, C.6
Wheeler, H.7
Simeone, J.F.8
Seaman, J.J.9
Knight, R.D.10
Heffernan, M.11
Mellars, K.12
Reitsma, D.J.13
-
27
-
-
0032491037
-
Reduction in new metastases in breast cancer with adjuvant clodronate treatment
-
IJ Diel EF Solomajer SD Costa C Gollan R Goerner D Wallwiener M Kauffmann G Bastert 1998 Reduction in new metastases in breast cancer with adjuvant clodronate treatment N Engl J Med 339 357 363
-
(1998)
N Engl J Med
, vol.339
, pp. 357-363
-
-
Diel, I.J.1
Solomajer, E.F.2
Costa, S.D.3
Gollan, C.4
Goerner, R.5
Wallwiener, D.6
Kauffmann, M.7
Bastert, G.8
-
28
-
-
0036682211
-
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
-
T Powles S Paterson JA Kanis E McCloskey S Ashley A Tidy K Rosenqvist I Smith L Ottestad S Legault M Pajunen A Nevantaus E Mannisto A Suovuori S Atula J Nevalainen L J Pylkkanen 2002 Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer J Clin Oncol 20 3219 3224
-
(2002)
J Clin Oncol
, vol.20
, pp. 3219-3224
-
-
Powles, T.1
Paterson, S.2
Kanis, J.A.3
McCloskey, E.4
Ashley, S.5
Tidy, A.6
Rosenqvist, K.7
Smith, I.8
Ottestad, L.9
Legault, S.10
Pajunen, M.11
Nevantaus, A.12
Mannisto, E.13
Suovuori, A.14
Atula, S.15
Nevalainen, J.16
Pylkkanen, L.J.17
-
29
-
-
0035148170
-
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a ramdomized controlled trial
-
T Saarto C Blomqvist P Virkkunen I Elomaa 2001 Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a ramdomized controlled trial J Clin Oncol 19 10 17
-
(2001)
J Clin Oncol
, vol.19
, pp. 10-17
-
-
Saarto, T.1
Blomqvist, C.2
Virkkunen, P.3
Elomaa, I.4
-
30
-
-
0030474026
-
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
-
JA Kanis T Powles AH Paterson EV McCloskey S Ashley 1996 Clodronate decreases the frequency of skeletal metastases in women with breast cancer Bone 19 663 667
-
(1996)
Bone
, vol.19
, pp. 663-667
-
-
Kanis, J.A.1
Powles, T.2
Paterson, A.H.3
McCloskey, E.V.4
Ashley, S.5
|